A phase 1 trial evaluating FSHR-targeting CAR T cells for patients with ovarian cancer has dosed the first patient in its ...

ZW-171 is under clinical development by Zymeworks and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase I drugs for Ovarian Cancer have a 73% phase transition success rate (PTSR) ...

Primary peritoneal cancer and fallopian tube cancer are similar to epithelial ovarian cancer and are treated in the same way. Germ cell ovarian tumours begin in the ovarian cells that develop into ...

Surufatinib is under clinical development by Hutchison MediPharma and currently in Phase II for Epithelial Ovarian Cancer.

A number of ovarian cancer vaccines are being evaluated including the world's first cancer prevention vaccine, which recently ...

Every woman has a one in 87 chance of getting ovarian cancer in her lifetime, and one in 130 will die from it.

Scientists discovered how cancer cells migrate by digesting the surrounding tissue matrix, enabling them to spread. A ...